Inhibitory effect and transcriptional impact of berberine and evodiamine on human white preadipocyte differentiation

被引:40
作者
Hu, Yueshan [1 ]
Fahmy, Hesham [1 ]
Zjawiony, Jordan K. [2 ,3 ]
Davies, Gareth E. [1 ,4 ,5 ]
机构
[1] S Dakota State Univ, Dept Pharmaceut Sci, Coll Pharm, Brookings, SD 57007 USA
[2] Univ Mississippi, Sch Pharm, Pharmaceut Sci Res Inst, University, MS 38677 USA
[3] Univ Mississippi, Sch Pharm, Dept Pharmacognosy, University, MS 38677 USA
[4] Avera Behav Hlth Ctr, Avera Inst Human Behav Genet, Sioux Falls, SD 57108 USA
[5] Univ S Dakota, Dept Psychiat, Sanford Sch Med, Vermillion, SD 57069 USA
关键词
Berberine; Evodiamine; Combination; Human white preadipocyte; Differentiation; GATA; ACTIVATED PROTEIN-KINASE; IN-VITRO; ADIPOCYTE DIFFERENTIATION; MECHANISM DISTINCT; SUPPRESSION; OBESITY; GAMMA; GATA;
D O I
10.1016/j.fitote.2009.09.012
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
It has been reported that the botanical alkaloids, berberine and evodiamine inhibit mouse preadipocyte 3T3-L1 differentiation. The aim of this study was to investigate the effect and transcriptional impact of berberine and evodiamine individually and in combination on human white preadipocyte (HWP) differentiation. We have shown that treatment with 8 mu M berberine or 4 mu M evodiamine resulted in a major inhibition of HWP differentiation accompanied by up-regulation of both GATA binding protein 2 and 3 (GATA-2 and GATA-3) mRNA and protein expression, suggesting that both compounds may have excellent potential as agents to prevent obesity. (C) 2009 Elsevier BM. All rights reserved.
引用
收藏
页码:259 / 268
页数:10
相关论文
共 43 条
[11]   Transcriptional control of adipocyte formation [J].
Farmer, Stephen R. .
CELL METABOLISM, 2006, 4 (04) :263-273
[12]   Years of life lost due to obesity [J].
Fontaine, KR ;
Redden, DT ;
Wang, CX ;
Westfall, AO ;
Allison, DB .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 289 (02) :187-193
[13]   Depletion of cAMP-response element-binding protein/ATF1 inhibits adipogenic conversion of 3T3-L1 cells ectopically expressing CCAAT/enhancer-binding protein (C/EBP) α, C/EBP β, or PPARγ2 [J].
Fox, Keith E. ;
Fankell, Dana M. ;
Erickson, Paul F. ;
Majka, Susan M. ;
Crossno, Joseph T., Jr. ;
Klemm, Dwight J. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (52) :40341-40353
[14]   Tea catechin suppresses adipocyte differentiation accompanied by down-regulation of PPARγ2 and C/EBPα in 3T3-L1 cells [J].
Furuyashiki, T ;
Nagayasu, H ;
Aoki, Y ;
Bessho, H ;
Hashimoto, T ;
Kanazawa, K ;
Ashida, H .
BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY, 2004, 68 (11) :2353-2359
[15]   AICAR inhibits adipocyte differentiation in 3T3L1 and restores metabolic alterations in diet-induced obesity mice model [J].
Giri, Shailendra ;
Rattan, Ramandeep ;
Haq, Ehtishamul ;
Khan, Mushfiquddin ;
Yasmin, Rifat ;
Won, Je-song ;
Key, Lyndon ;
Singh, Avtar K. ;
Singh, Inderjit .
NUTRITION & METABOLISM, 2006, 3 (1)
[16]   Berberine increases expression of GATA-2 and GATA-3 during inhibition of adipocyte differentiation [J].
Hu, Y. ;
Davies, G. E. .
PHYTOMEDICINE, 2009, 16 (09) :864-873
[17]   Berberine inhibits 3T3-L1 adipocyte differentiation through the PPARγ pathway [J].
Huang, Cheng ;
Zhang, Yuebo ;
Gong, Zhenwei ;
Sheng, Xiaoyan ;
Li, Zongmeng ;
Zhang, Wei ;
Qin, Ying .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2006, 348 (02) :571-578
[18]  
Huang K. C., 1999, PHARM CHINESE HERBS, P381
[19]   Capsaicin-like anti-obese activities of evodiamine from fruits of Evodia rutaecarpa, a vanilloid receptor agonist [J].
Kobayashi, Y ;
Nakano, Y ;
Kizaki, M ;
Hoshikuma, K ;
Yokoo, Y ;
Kamiya, T .
PLANTA MEDICA, 2001, 67 (07) :628-633
[20]   Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins [J].
Kong, WJ ;
Wei, J ;
Abidi, P ;
Lin, MH ;
Inaba, S ;
Li, C ;
Wang, YL ;
Wang, ZZ ;
Si, SY ;
Pan, HN ;
Wang, SK ;
Wu, JD ;
Wang, Y ;
Li, ZR ;
Liu, JW ;
Jiang, JD .
NATURE MEDICINE, 2004, 10 (12) :1344-1351